The proform of eosinophil major basic protein: A new maternal serum marker for adverse pregnancy outcome

Prenatal Diagnosis

Volumn 29, Issue 11, 2009, Pages 1013-1019

  Pihl, Kasper ^a   Larsen, Torben ^b   Rasmussen, Steen ^c   Krebs, Lone ^b   Christiansen, Michael ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Sundhedsstyrelsen   (Denmark)

Author keywords

First trimester; Preeclampsia; Preterm delivery; proMBP; Serum markers; SGA

Indexed keywords

BIOLOGICAL MARKER; MAJOR BASIC PROTEIN;

ADOLESCENT; ADULT; ADVERSE OUTCOME; AREA UNDER THE CURVE; ARTICLE; CASE CONTROL STUDY; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MATERNAL SERUM; NULLIPARA; PREDICTION; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL SCREENING; PRIORITY JOURNAL; RANK SUM TEST; RECEIVER OPERATING CHARACTERISTIC; SMALL FOR DATE INFANT; TASK PERFORMANCE;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BLOOD PROTEINS; CASE-CONTROL STUDIES; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; OBSTETRIC LABOR, PREMATURE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PROGNOSIS; PROTEIN PRECURSORS; PROTEOGLYCANS; YOUNG ADULT;

EID: 70350459892     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2331     Document Type: Article

References (48)

1. Akolekar R, Zaragoza E, Poon LC, Pepes S, Nicolaides KH. 2008. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 32: 732-739.
2. Bale LK, Conover CA. 2005. Disruption of insulin-like growth factor-II imprinting during embryonic development rescues the dwarf phenotype of mice null for pregnancy-associated plasma protein-A. J Endocrinol 186: 325-331.
3. Barker RL, Gleich GJ, Pease LR. 1988. Acidic precursor revealed in human eosinophil granule major basic protein cDNA. J Exp Med 168: 1493-1498. (Pubitemid 18264882)
4. Barker RL, Gundel RH, Gleich GJ, et al. 1991. Acidic polyamino acids inhibit human eosinophil granule major basic protein toxicity. Evidence of a functional role for ProMBP. J Clin Invest 88: 798-805.
5. Brown MA, Lindheimer MD, de SM, van AA, Moutquin JM. 2001. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 20: IX-XIV.
6. Christiansen M, Larsen SO. 2002. An increase in cost-effectiveness of first trimester maternal screening programmes for fetal chromosome anomalies is obtained by contingent testing. Prenat Diagn 22: 482-486. (Pubitemid 34716938)
7. Christiansen M, Oxvig C, Wagner JM, et al. 1999. The proform of eosinophil major basic protein: a new maternal serum marker for Down syndrome. Prenat Diagn 19: 905-910. (Pubitemid 29476218)
8. Christiansen M, Jaliashvili I, Overgaard MT, Ensinger C, Obrist P, Oxvig C. 2000. Quantification and characterization of pregnancy-associated complexes of angiotensinogen and the proform of eosinophil major basic protein in serum and amniotic fluid. Clin Chem 46: 1099-1105. (Pubitemid 30643311)
9. Christiansen M, Larsen SO, Oxvig C, et al. 2004. Screening for Down's syndrome in early and late first and second trimester using six maternal serum markers. Clin Genet 65: 11-16. (Pubitemid 38111397)
10. Clausson B, Cnattingius S, Axelsson O. 1998. Preterm and term births of small for gestational age infants: a population-based study of risk factors among nulliparous women. Br J Obstet Gynaecol 105: 1011-1017. (Pubitemid 28442328)
11. Cnattingius S. 2004. The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob Res 6(Suppl 2): S125-S140. (Pubitemid 38678838)
12. Cosin-Sales J, Christiansen M, Kaminski P, et al. 2004. Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation 109: 1724-1728. (Pubitemid 38500673)
13. Cowans NJ, Spencer K. 2007. First-trimester ADAM12 and PAPPA as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat Diagn 27: 264-271. (Pubitemid 46450586)
14. Dugoff L, Hobbins JC, Malone FD, et al. 2004. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol 191: 1446-1451. (Pubitemid 39421612)
15. Duley L, Henderson-Smart DJ, Meher S, King JF. 2007. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev Article no. CD004659. (Pubitemid 351805710)
16. England L, Zhang J. 2007. Smoking and risk of preeclampsia: a systematic review. Front Biosci 12: 2471-2483.
17. Esplin MS, Fausett MB, Fraser A, et al. 2001. Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med 344: 867-872. (Pubitemid 32224394)
18. Filley WV, Holley KE, Kephart GM, Gleich GJ. 1982. Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet 2: 11-16.
19. Gardosi J, Francis A. 2007. Customised Centile Calculator - GROW-Centile v 5.12. Gestation Network, www.gestation.net.
20. Giudice LC, Conover CA, Bale L, et al. 2002. Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation. J Clin Endocrinol Metab 87: 2359-2366. (Pubitemid 34521531)
21. Gleich GJ, Loegering DA, Maldonado JE. 1973. Identification of a major basic protein in guinea pig eosinophil granules. J Exp Med 137: 1459-1471.
22. Gleich GJ, Adolphson CR, Leiferman KM. 1993. The biology of the eosinophilic leukocyte. Annu Rev Med 44: 85-101.
23. Huppertz B. 2008. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 51: 970-975.
24. Krantz D, Goetzl L, Simpson JL, et al. 2004. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 191: 1452-1458. (Pubitemid 39421613)
25. Lindqvist PG, Molin J. 2005. Does antenatal identification of small-for-gestational age fetuses significantly improve their outcome? Ultrasound Obstet Gynecol 25: 258-264. (Pubitemid 40432693)
26. Morris JK, Wald NJ. 2007. The effect of correlations between screening markers on screening performance. J Med Screen 14: 151-157.
27. Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. 2000. Risk factors and clinical manifestations of pre-eclampsia. BJOG 107: 1410-1416.
28. Overgaard MT, Oxvig C, Christiansen M, et al. 1999. Messenger ribonucleic acid levels of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein: expression in human reproductive and nonreproductive tissues. Biol Reprod 61: 1083-1089. (Pubitemid 29455648)
29. Overgaard MT, Haaning J, Boldt HB, et al. 2000. Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor. J Biol Chem 275: 31128-31133. (Pubitemid 30757773)
30. Oxvig C, Sand O, Kristensen T, Gleich GJ, Sottrup-Jensen L. 1993. Circulating human pregnancy-associated plasma protein-A is disulfide-bridged to the proform of eosinophil major basic protein. J Biol Chem 268: 12243-12246. (Pubitemid 23182369)
31. Oxvig C, Haaning J, Kristensen L, et al. 1995. Identification of angiotensinogen and complement C3dg as novel proteins binding the proform of eosinophil major basic protein in human pregnancy serum and plasma. J Biol Chem 270: 13645-13651.
32. Peters MS, Rodriguez M, Gleich GJ. 1986. Localization of human eosinophil granule major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin by immunoelectron microscopy. Lab Invest 54: 656-662. (Pubitemid 16040362)
33. Pihl K, Larsen T, Krebs L, Christiansen M. 2008a. First trimester maternal serum PAPP-A, beta-hCG and ADAM12 in prediction of small-for- gestational-age fetuses. Prenat Diagn 28: 1131-1135.
34. Pihl K, Sorensen TL, Norgaard-Pedersen B, et al. 2008b. First-trimester combined screening for Down syndrome: prediction of low birth weight, small for gestational age and pre-term delivery in a cohort of non-selected women. Prenat Diagn 28: 247-253.
35. Pijnenborg R, Vercruysse L, Hanssens M. 2006. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 27: 939-958. (Pubitemid 44204033)
36. Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH. 2007. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 30: 742-749. (Pubitemid 47612696)
37. Plasencia W, Maiz N, Poon L, Yu C, Nicolaides KH. 2008. Uterine artery Doppler at 11 +0 to 13+ 6 weeks and 21 +0 to 24+ 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 32: 138-146.
38. Poon LC, Maiz N, Valencia C, Plasencia W, Nicolaides KH. 2009. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstet Gynecol 33: 23-33.
39. Prefumo F, Canini S, Crovo A, Pastorino D, Venturini PL, De BP. 2006. Correlation between first trimester fetal bone length and maternal serum pregnancy-associated plasma protein-A (PAPP-A). Hum Reprod 21: 3019-3021.
40. Roberts CT, Owens JA, Sferruzzi-Perri AN. 2008. Distinct actions of insulin-like growth factors (IGFs) on placental development and fetal growth: lessons from mice and guinea pigs. Placenta 29(Suppl A): S42-S47.
41. Robinson HP, Fleming JE. 1975. A critical evaluation of sonar "crown-rump length" measurements. Br J Obstet Gynaecol 82: 702-710.
42. Rode L, Wojdemann KR, Shalmi AC, et al. 2003. Combined first- and second-trimester screening for Down syndrome: an evaluation of proMBP as a marker. Prenat Diagn 23: 593-598. (Pubitemid 36917383)
43. Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. 2002. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 87: 1762-1767.
44. Spencer K, Cowans NJ, Chefetz I, Tal J, Meiri H. 2007. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Ultrasound Obstet Gynecol 29: 128-134. (Pubitemid 46326583)
45. Spencer K, Cowans NJ, Nicolaides KH. 2008. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia. Prenat Diagn 28(1): 7-10. (Pubitemid 351251982)
46. Tewksbury DA, Dart RA. 1982. High molecular weight angiotensinogen levels in hypertensive pregnant women. Hypertension 4: 729-734.
47. Tewksbury DA, Kaiser SJ, Burrill RE. 2001. A study of the temporal relationship between plasma high molecular weight angiotensinogen and the development of pregnancy-induced hypertension. Am J Hypertens 14: 794-797.
48. von DP, Magee LA, Roberts JM. 2003. Subclassification of preeclampsia. Hypertens Pregnancy 22: 143-148.